Onlyric 80mg Tablet contains Febuxostat, a xanthine oxidase inhibitor indicated for the management of hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and the formation of urate crystals in joints and tissues. Onlyric 80mg is typically prescribed for patients who are intolerant to or inadequately controlled by allopurinol. The tablet should be taken orally, with or without food, as directed by a healthcare professional. Dose adjustments may be necessary based on renal function and patient response. Common adverse effects include liver function abnormalities, nausea, rash, and joint pain. It is essential to monitor liver enzymes periodically during treatment. Febuxostat is contraindicated in patients with a history of hypersensitivity to the drug and should be used cautiously in those with cardiovascular disease due to an observed increased risk of cardiovascular events. Patients are advised to maintain adequate hydration to prevent kidney stone formation. Onlyric 80mg Tablet should be used under strict medical supervision to ensure efficacy and safety.